Profile
INBS DHR-PB TMO DHR IDXX A
Company Name Intelligent Bio Solutions Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $11.95M $916.76B $164.16B $145.42B $42.74B $33.87B
Employees 0.05K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Harry Simeonidis Rainer M. Blair Marc N. Casper Rainer M. Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
INBS DHR-PB TMO DHR IDXX A
Quant Rating Score 3 5 3 3 3 3
Quant Rating Neutral Strong Buy Neutral Neutral Neutral Neutral
Trading
INBS DHR-PB TMO DHR IDXX A
Last Close $1.73 $1261.26 $425.34 $197.75 $531.42 $120.08
High 52 $2.64 $1261.26 $624.21 $280.76 $547.01 $152.6
Low 52 $1.07 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High -34.47 % 0 % -31.86 % -29.57 % -2.85 % -21.31 %
Price vs. 52 Week Low 61.68 % 0 % 9.01 % 13.23 % 47.19 % 20.94 %
Total Return
INBS DHR-PB TMO DHR IDXX A
1 Month Return -9.42 % 0 % 5.61 % -1.46 % 1.67 % 2.56 %
3 Month Return 37.3 % 0 % -3.56 % 4.12 % 31.53 % 16.45 %
6 Month Return 32.06 % 0 % -22.87 % -16.9 % 25.65 % -15.57 %
9 Month Return 18.49 % 0 % -29.17 % -27.48 % 12.13 % -16.95 %
YTD Return 23.57 % 0 % -18.24 % -13.85 % 28.54 % -10.61 %
1 Year Return -10.36 % 0 % -21.91 % -19.69 % 10.09 % -8.34 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
INBS DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.58 % 0.38 % 0.58 % - 0.82 %
Dividend Paid and Capex Coverage Ration (TTM) -23.05 % 2.93 % 4.05 % 2.93 % 7.41 % 3.43 %
Dividend Per Share (TTM) - 1.18 % 1.64 % 1.18 % - 0.98 %
Payout Ratio (TTM) - 20.85 % 9.16 % 20.85 % - 23.76 %
Profitability
INBS DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 59.72 % 59.74 % 41.57 % 59.74 % 61.32 % 53.79 %
Return on Assets TTM -93.44 % 4.76 % 6.58 % 4.76 % 27.85 % 9.59 %
Return on Equity TTM -149.8 % 7.47 % 13.34 % 7.47 % 57.35 % 19.46 %
Return on Capital Employed TTM -209.17 % 6.66 % 8.53 % 6.66 % 55.24 % 13.97 %
Net Income Per EBT TTM 84.47 % 83.59 % 92.18 % 83.59 % 79.59 % 85.05 %
EBT Per Ebit TTM 100.96 % 93.35 % 96.45 % 93.35 % 97.98 % 96.75 %
EBIT Per Revenue TTM -289.4 % 20.26 % 17.08 % 20.26 % 29.19 % 21.38 %
Cash Flow To Debt Ratio TTM -2165.31 % 37.92 % 23.81 % 37.92 % 91.41 % 45.35 %
Receivables Turnover TTM 7.1 6.79 5.07 6.79 6.51 4.85
Payables Turnover TTM - 5.57 - 5.57 12.66 5.94
Inventory Turnover TTM 2.14 3.79 4.8 3.79 3.84 3.1
Fixed Asset Turnover TTM 538.94 % 466.14 % 459.74 % 466.14 % 471.66 % 346.65 %
Asset Turnover TTM 37.86 % 30.11 % 43.31 % 30.11 % 122.35 % 54.52 %
Operating Cash Flow Per Share TTM -1.92 8.72 21.53 8.72 11.91 5.56
Free Cash Flow Per Share TTM -2 6.84 17.79 6.84 10.3 4.91
Cash Per Share TTM 48.63 % 278.24 % 1573.28 % 278.24 % 201.64 % 521.4 %
Operating Cash Flow Sales Ratio TTM -305.05 % 26.23 % 18.97 % 26.23 % 24.63 % 23.91 %
Free Cash Flow Operating Cash Flow Ratio TTM 104.34 % 78.46 % 82.61 % 78.46 % 86.51 % 88.33 %
Cash Flow Coverage Ratios TTM -2165.31 % 37.92 % 23.81 % 37.92 % 91.41 % 45.35 %
Price To Free Cash Flows Ratio TTM -0.04 29.67 24.41 29.67 51.02 24.2
Price To Operating Cash Flows Ratio TTM -0.25 23.3 20.2 23.3 44.63 21.44
Price Cash Flow Ratio TTM -0.25 23.3 20.2 23.3 44.63 21.44
Income Statement (TTM)
INBS DHR-PB TMO DHR IDXX A
Revenue $0B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $0B $14.21B $17.7B $14.21B $2.38B $3.54B
Gross Profit Ratio 45.82% 59.5% 41.28% 59.5% 61.04% 54.3%
EBITDA $-0.01B $7.28B $11.8B $7.28B $1.28B $1.87B
Net Income $-0.01B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -6.38 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
INBS DHR-PB TMO DHR IDXX A
Long Term Debt $0B $15.5B $29.06B $15.5B $0.55B $3.35B
Total Liabilities $0.01B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $0.01B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $0B $1.56B $0B $0.06B $0.18B
Total Debt $0B $16.01B $31.28B $16.01B $0.99B $3.39B
Total Assets $0.01B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
INBS DHR-PB TMO DHR IDXX A
Net Income $-0.01B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $0B $0.15B $0B $0.15B $-0.03B $0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $-0.01B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 112.93
ACRS Aclaris Therapeutics, Inc. 1.53
ADVB Advanced Biomed Inc. Common Stock 0.7582
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 4.98
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.3015
BIAF bioAffinity Technologies, Inc. 0.2967
BIAFW bioAffinity Technologies, Inc. 0.1814
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 3.38
BNR Burning Rock Biotech Limited 4.86
CDNA CareDx, Inc 19.005
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.735
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 154.42
CSTL Castle Biosciences, Inc. 18.87
DGX Quest Diagnostics Incorporated 166.36
ETFs With Exposure to INBS
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0.00002 194.505
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00002 149.84
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00002 149.85
VEMPX Vanguard Extended Market Index InstlPlus 0.00002 369.78
Unlock